Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA 2020 Novel Approval Count Rises To 53 At CDER, Plus 5 New CBER Biologics
Jan 01 2021
•
By
Bridget Silverman
While not a high-water mark, US FDA's 2020 approval total is still one for the history books • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pink Sheet Perspectives
More from Pink Sheet